Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Bellevue Life Sciences Acquisition Corp. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21
Revenues0.10.0
            Revenue growth969.8% 
Cost of goods sold0.00.0
Gross profit0.10.0
            Gross margin100.0%100.0%
Selling, general and administrative0.00.0
EBIT0.00.0
            EBIT margin50.0%50.0%
Pre-tax income0.00.0
Income taxes0.00.0
            Tax rate0.0%0.0%
Net income0.00.0
            Net margin-50.0%-50.0%
 
Diluted EPS($0.02)$0.00
Shares outstanding (diluted)1.51.5
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy